Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Bristol-Myers Squibb Company (BMY)

Healthcare Drug Manufacturers - General
65.30 $
+0.7% vs. previous close
Closing price · As of: 31. Jul 2026

Bristol-Myers Squibb Company (BMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 90,038 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet BMY
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
33,749 31,748 33,707 33,551 34,986 129,944 118,481 109,314 96,820 95,159 92,603 90,038
14,608 10,415 13,704 14,854 17,716 29,354 30,192 33,262 27,273 31,770 29,780 29,390
5,571 2,385 4,237 5,421 6,911 12,346 14,546 13,979 9,123 11,464 10,346 10,209
7,435 4,270 6,350 6,812 8,759 15,393 16,450 17,221 9,253 12,280 10,859 10,673
3,390 4,299 5,543 6,300 5,747 7,685 10,554 12,516 13,937 15,264 14,424 14,525
1,560 1,221 1,241 1,166 1,195 4,293 2,074 2,095 2,339 2,662 2,557 2,690
4,417 4,412 4,980 5,001 5,027 6,252 5,886 6,049 6,255 8,036 8,360 9,125
7,027 6,881 6,875 6,863 6,538 22,488 20,547 20,502 21,149 21,169 21,719 21,754
1,753 1,419 1,385 1,210 1,091 63,969 53,449 42,775 36,355 27,485 23,643 19,103
18,766 17,324 17,360 21,704 20,859 78,246 80,599 73,308 65,702 65,674 76,215 71,532
8,461 8,017 8,841 9,563 10,654 18,304 19,080 21,868 21,890 22,262 23,774 23,417
590 139 992 987 1,703 3,479 2,504 5,117 4,400 3,281 2,227 2,463
2,487 1,565 1,664 2,248 1,892 2,445 2,713 2,949 3,040 3,259 3,602 3,575
7,242 6,550 5,716 6,975 5,646 43,387 48,336 39,605 35,056 36,653 47,603 42,850
14,852 14,266 16,177 11,741 14,031 51,598 37,822 35,946 31,061 29,430 16,335 18,473
32,541 31,613 33,513 31,160 34,065 34,474 21,281 23,820 25,503 28,766 14,912 16,896
1,670 1,679 1,680 1,652 1,637 1,712 2,258 2,245 2,146 2,078 2,027 2,041

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?